Antacid therapy (AAT) may lead to major digestive problems and severe lung infections in idiopathic pulmonary fibrosis (IPF) patients who take Esbriet (pirfenidone), a study reports. The research, “Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone” was published in the journal…
Antacid Therapy May Lead to Lung Infections in Esbriet-Treated IPF Patients, Study Reports
Boehringer Ingelheim has enrolled its first patient with progressive fibrosing interstitial lung disease (PF-ILD) in a Phase 3 clinical trial investigating the effectiveness and safety of treatment with Ofev (nintedanib). Patients with ILDs, also called diffuse parenchymal lung diseases, are often unable to breathe. The problem stems from impaired gas exchange — a consequence…
When you are diagnosed with a life-threatening illness such as pulmonary fibrosis, it is inevitable that you will feel the need to ask some big questions. Dreaded questions like “Why me?” “Why did this have to happen?” “Am I going to die?” and “How long do I…
Esbriet (pirfenidone), is an anti-fibrotic drug used in the treatment of patients with mild to moderate idiopathic pulmonary fibrosis (IPF). It’s made by the pharmaceutical company, Genentech. Find out more about Esbriet for treating idiopathic pulmonary fibrosis. A study by researchers at the University of Wisconsin found that…
ProMetic Life Sciences’s lead product for the treatment of idiopathic pulmonary fibrosis (IPF), called PBI-4050, is going to be tested in a Phase 2/3 clinical trial. Supported by efficacy data from a Phase 2 study (NCT02538536), the U.S. Food and Drug Administration (FDA) has accepted the…
When diagnosing patients with pulmonary fibrosis (PF), doctors will use a spirometry device to determine the severity of the condition. A forced vital capacity test (FVC) is needed to assess how efficiently a PF patient can breathe; patients take a deep breath and then exhale into the spirometry device for…
Bristol-Myers Squibb and Nordic Bioscience will collaborate on the development of biomarkers that can help diagnose and keep tabs on the status of fibrotic diseases like pulmonary fibrosis (PF). A biomarker is a molecule that can be used to diagnose a disease or predict its progression by…
I started noticing a change in my vision about a year ago. I’ve had the same prescription for glasses and contact lenses for 20 years. I was diagnosed with pulmonary fibrosis almost three years ago, and didn’t notice any changes in my vision for…
Healthy Air is an initiative run by the American Lung Association (ALA) that aims to education people on how to improve the air they breathe, avoid pollution and help influence public policy to improve the air quality. MORE: Four ways the American Lung Association helps patients manage their lung disease.
Throughout this yearlong journey with idiopathic pulmonary fibrosis (IPF), to which I am an unwilling participant, I have often spoken with others about the benefits of having something positive to look forward to. Knowing something good is on the horizon helps in coping with this disease — whether…
